Does CYTARABINE Cause Activated partial thromboplastin time prolonged? 44 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 44 reports of Activated partial thromboplastin time prolonged have been filed in association with CYTARABINE (cytarabine). This represents 0.1% of all adverse event reports for CYTARABINE.
44
Reports of Activated partial thromboplastin time prolonged with CYTARABINE
0.1%
of all CYTARABINE reports
11
Deaths
30
Hospitalizations
How Dangerous Is Activated partial thromboplastin time prolonged From CYTARABINE?
Of the 44 reports, 11 (25.0%) resulted in death, 30 (68.2%) required hospitalization, and 5 (11.4%) were considered life-threatening.
Is Activated partial thromboplastin time prolonged Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for CYTARABINE. However, 44 reports have been filed with the FAERS database.
What Other Side Effects Does CYTARABINE Cause?
Febrile neutropenia (6,142)
Off label use (4,183)
Pyrexia (2,992)
Neutropenia (2,558)
Disease progression (2,352)
Drug ineffective (2,281)
Thrombocytopenia (2,148)
Sepsis (2,013)
Myelosuppression (1,869)
Product use in unapproved indication (1,619)
What Other Drugs Cause Activated partial thromboplastin time prolonged?
DABIGATRAN ETEXILATE (264)
HEPARIN (225)
RIVAROXABAN (163)
WARFARIN (146)
ACETAMINOPHEN (119)
ALLOPURINOL (110)
AMIODARONE (99)
METRONIDAZOLE (98)
SIMVASTATIN (94)
DARBEPOETIN ALFA (93)
Which CYTARABINE Alternatives Have Lower Activated partial thromboplastin time prolonged Risk?
CYTARABINE vs CYTARABINE\DAUNORUBICIN
CYTARABINE vs DABIGATRAN
CYTARABINE vs DABIGATRAN ETEXILATE
CYTARABINE vs DABRAFENIB
CYTARABINE vs DABRAFENIB\TRAMETINIB